Good news, here. Let’s hope the NHS funds this test sooner rather than later…
Mail on Sunday 26.4.15 “CELL CHECK SPARES WOMEN CHEMO FOR BREAST CANCER”
Breast cancer patients may be spared chemotherapy thanks to new tests that pinpoint genetic markers in the tumour which determine its aggressiveness. After surgery, the cancer cells are sent to a lab to be tested & women can be told within days if they have a high or low risk of the cancer returning. Most women with breast cancer are routinely given gruelling drug treatment which has side effects, including complete hair loss, nausea, sickness, extreme fatigue etc. If the newest test, EndoPredict, shows a low score patients can opt not to have chemo. Most of the tests are available only privately & cost about £2,500, although breast specialists hope they may soon become available on NHS.
